Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

21,959 public trials 3,762 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

VIBRANT: VIB4920 for Active Lupus Nephritis

NCT05201469

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • University of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology La Jolla, California, United States
  • UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States
  • of California, Irvine School of Medicine Division of Rheumatology Orange, California, United States
  • University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

NCT06963827

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Disease, +4 more
Locations
  • UAB Nephrology Research Clinic at Paula Building Birmingham, Alabama, United States
  • DCR Montgomery Montgomery, Alabama, United States
  • Panoramic Health - Southwest Kidney Institute, PLC Surprise, Arizona, United States
  • Panoramic Health - West Coast Kidney Institute (Fremont) Fremont, California, United States
View all 177 locations
View Trial Details
Recruiting

A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+

NCT07326215

Conditions
Acute Kidney Injury, Acute Respiratory Distress Syndrome, Female Urogenital Diseases, +10 more
Locations
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The University of Hong Kong-Shenzhen Hospital Shenzhen, Guangdong, China
  • The First Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT07213609

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +22 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site Canton, Ohio, United States
  • GSK Investigational Site Nashville, Tennessee, United States
View all 27 locations
View Trial Details

Related conditions